DHR
Price
$192.13
Change
-$0.95 (-0.49%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
184.93B
53 days until earnings call
QDEL
Price
$29.89
Change
-$1.19 (-3.83%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
3.14B
56 days until earnings call
Interact to see
Advertisement

DHR vs QDEL

Header iconDHR vs QDEL Comparison
Open Charts DHR vs QDELBanner chart's image
Danaher
Price$192.13
Change-$0.95 (-0.49%)
Volume$13.85K
Capitalization184.93B
QuidelOrtho
Price$29.89
Change-$1.19 (-3.83%)
Volume$11.58K
Capitalization3.14B
DHR vs QDEL Comparison Chart
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. QDEL commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and QDEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (DHR: $192.15 vs. QDEL: $29.90)
Brand notoriety: DHR and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 72% vs. QDEL: 66%
Market capitalization -- DHR: $184.93B vs. QDEL: $3.14B
DHR [@Medical Specialties] is valued at $184.93B. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, both DHR and QDEL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 5 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 4 bearish.
  • QDEL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DHR is a better buy in the short-term than QDEL.

Price Growth

DHR (@Medical Specialties) experienced а +0.88% price change this week, while QDEL (@Medical Specialties) price change was -2.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.32%. For the same industry, the average monthly price growth was +4.56%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

DHR is expected to report earnings on Jul 29, 2025.

QDEL is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than QDEL($3.14B). DHR has higher P/E ratio than QDEL: DHR (43.86) vs QDEL (9.76). DHR YTD gains are higher at: -16.165 vs. QDEL (-30.236). DHR has higher annual earnings (EBITDA): 7.5B vs. QDEL (607M). DHR has more cash in the bank: 5.86B vs. QDEL (167M). QDEL has less debt than DHR: QDEL (2.61B) vs DHR (19.5B). DHR has higher revenues than QDEL: DHR (23.9B) vs QDEL (3B).
DHRQDELDHR / QDEL
Capitalization185B3.14B5,888%
EBITDA7.5B607M1,235%
Gain YTD-16.165-30.23653%
P/E Ratio43.869.76450%
Revenue23.9B3B797%
Total Cash5.86B167M3,511%
Total Debt19.5B2.61B746%
FUNDAMENTALS RATINGS
DHR vs QDEL: Fundamental Ratings
DHR
QDEL
OUTLOOK RATING
1..100
959
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
63100
SMR RATING
1..100
7894
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
7914
SEASONALITY SCORE
1..100
6575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (48) in the Medical Specialties industry is in the same range as QDEL (56). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

DHR's Profit vs Risk Rating (63) in the Medical Specialties industry is somewhat better than the same rating for QDEL (100). This means that DHR’s stock grew somewhat faster than QDEL’s over the last 12 months.

DHR's SMR Rating (78) in the Medical Specialties industry is in the same range as QDEL (94). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

DHR's Price Growth Rating (63) in the Medical Specialties industry is in the same range as QDEL (64). This means that DHR’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for DHR (79). This means that QDEL’s stock grew somewhat faster than DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRQDEL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
65%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEPCX58.130.39
+0.68%
American Funds EUPAC C
HNASX19.01N/A
N/A
Homestead Growth
BOGIX29.95N/A
N/A
SGI Small Cap Core Fund I Shares
HMVSX16.92N/A
N/A
Hartford MidCap Value R4
VSENX52.45N/A
N/A
JPMorgan Small Cap Equity R6

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with DHR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
+2.61%
DHR - QDEL
50%
Loosely correlated
+0.53%
IQV - QDEL
50%
Loosely correlated
+3.59%
AZTA - QDEL
50%
Loosely correlated
+7.47%
BIO - QDEL
49%
Loosely correlated
+0.67%
XRAY - QDEL
49%
Loosely correlated
+1.32%
More